产品说明书
Pembrolizumab
 |
同义名 : | MK-3475;Lambrolizumab |
| CAS号 : | 1374853-91-4 | |
| 货号 : | A1174800 | |
| 分子式 : | - | |
| 纯度 : | 98% | |
| 分子量 : | 0 | |
| MDL号 : | N/A | |
| 存储条件： |
粉末 Sealed in dry,under -80°C 液体 -20°C:3-6个月-80°C:24个月 |
|
| 溶解度 : | - | |
| 动物实验配方： |
| 生物活性 | |||
|---|---|---|---|
| 靶点 |
|
||
| 描述 | Product Name: Pembrolizumab Corss-reactivity: Human,Cynomolgus Organism：Human Target name: PDCD1 / PD-1 / CD279 Recommended Dilution Buffer: Sterile PBS or 0.9% saline for reconstitution/dilution. It is recommended to use the reconstituted/diluted product within one month. Formulation: 100 mM Pro-Ac，20 mM Arg，pH5.0 Endotoxin: < 0.001EU/μg, determined by LAL method. Purity: >95%. Determined by SDS-PAGE Purification: Purified, Protein A, affinity column Storage: -80°C for 2 years under sterile conditions； -20°C for 1 year under sterile conditions； Avoid repeated freeze-thaw cycles. Isotype: IgG4SP-Kappa |
||